Ambrisentan Tablet, Film Coated
Product Images NDC 70710-1179

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ambrisentan (NDC 70710-1179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

18d85ac0 9b44 49a9 8a8b 81005dc7977d 01

FDA Label Image

18d85ac0 9b44 49a9 8a8b 81005dc7977d 02

This appears to be a chart of interacting drugs with Ambrisentan, a medication used to treat pulmonary arterial hypertension. The chart includes 10 other drugs, such as Cyclosporine and Mycophenolate Mofetil, with recommendations on whether or not to adjust the dose of Ambrisentan when used in combination with each drug. The column "PR" is not defined and the numbers across the bottom appear to indicate a "fold change" relative to Ambrisentan alone.*

FDA Label Image

18d85ac0 9b44 49a9 8a8b 81005dc7977d 03

This is a list of drugs and their interactions with other drugs. It also includes PK information such as Cmax and AUC. There are no recommended dose adjustments for any of the drugs listed.*

FDA Label Image

18d85ac0 9b44 49a9 8a8b 81005dc7977d 04

FDA Label Image

18d85ac0 9b44 49a9 8a8b 81005dc7977d 05

This appears to be a graphical representation of clinical trial data for the drugs Ambrisentan and Placebo, in two different trials (ARIES-1 and ARIES-2), plotted against time in weeks. The y-axis represents the percentage of patients who remained in the study at that time point, while the x-axis shows the time elapsed in weeks. The number of patients at risk at each time point is also included.*

FDA Label Image

18d85ac0 9b44 49a9 8a8b 81005dc7977d 06

FDA Label Image

18d85ac0 9b44 49a9 8a8b 81005dc7977d 07

This is a medication label for Ambrisentan tablets, which should not be split, crushed, or chewed. The usual dosage should be determined by the prescribing information. The tablets should be stored at a temperature between 20°C to 25°C, with excursions permitted up to 15°C to 30°C. The medication should be dispensed in the original container, which should be kept tightly closed. The label also includes the medication's NDC number, manufacturer (Cadila Healthcare Ltd in Ahmedabad, India), and an instruction to the pharmacist to dispense the medication with the accompanying information.*

FDA Label Image

18d85ac0 9b44 49a9 8a8b 81005dc7977d 08

This is a description of medication named Ambrisentan. The tablets come in a pack of 30 and are dispensed under prescription only. Each tablet contains 10mg of the Ambrisentan. The usual dosage information is provided in the accompanying prescription information. The tablets are film-coated and must not be split, crushed, or chewed. They should be stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F). The medication should be kept in the original container, and the accompanying medication guide should be provided to each patient. The manufacturer of the medication is Cadla Healthcare Ltd Ahmedabed, India, and it is distributed by Zydus Pharmaceuticals (USA) Inc. in Penringlon, NJ 08534.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.